dimethyl sulfoxide has been researched along with Carcinoma, Small Cell in 5 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A low concentration of differentiation inducers such as dimethylsulphoxide (DMSO), sodium butyrate, hexamethylene bisacetamide and sodium phenylacetate greatly enhanced the antiproliferative effect in vitro and in vivo of interferon alpha (IFN-alpha) to several human lung adenocarcinoma cells." | 3.69 | Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents. ( Goto, I; Honma, Y; Yamamoto-Yamaguchi, Y, 1996) |
| " The SCLC cell lines, NCI-H69, NCI-H146 and NCI-H209, showed a dose-response (tested between 0." | 1.31 | Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. ( Griffin, JD; Healy, ME; Johnson, BE; Lin, J; Maulik, G; Salgia, R; Sattler, M; Stiles, CD; Verma, S; Wang, WL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, I | 1 |
| Yamamoto-Yamaguchi, Y | 1 |
| Honma, Y | 1 |
| Nakae, T | 1 |
| Horai, T | 1 |
| Imamura, F | 1 |
| Akedo, H | 1 |
| Higashino, K | 1 |
| Wang, WL | 1 |
| Healy, ME | 1 |
| Sattler, M | 1 |
| Verma, S | 1 |
| Lin, J | 1 |
| Maulik, G | 1 |
| Stiles, CD | 1 |
| Griffin, JD | 1 |
| Johnson, BE | 1 |
| Salgia, R | 1 |
| Giaccone, G | 1 |
| Broers, J | 1 |
| Jensen, S | 1 |
| Fridman, RI | 1 |
| Linnoila, R | 1 |
| Gazdar, AF | 1 |
| Munker, M | 1 |
| Munker, R | 1 |
| Saxton, RE | 1 |
| Koeffler, HP | 1 |
5 other studies available for dimethyl sulfoxide and Carcinoma, Small Cell
| Article | Year |
|---|---|
Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents.
Topics: Acetamides; Adenocarcinoma; Alkaline Phosphatase; Animals; Antineoplastic Agents; Biomarkers; Butyra | 1996 |
Expression of cathepsin B in small cell lung carcinoma cells in relation to in vitro invasiveness.
Topics: Carcinoma, Small Cell; Cathepsin B; Cell Aggregation; Cell Division; Cell Line; Cells, Cultured; Dim | 1998 |
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; C | 2000 |
Increased expression of differentiation markers can accompany laminin-induced attachment of small cell lung cancer cells.
Topics: Acetamides; Actins; Bucladesine; Carcinoma, Small Cell; Cell Adhesion; Cell Differentiation; Cell Di | 1992 |
Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.
Topics: Calcitriol; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Di | 1987 |